Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Allergic reaction to the first shot; This serious case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced allergic reaction (Verbatim: Allergic reaction to the first shot) (serious criteria other: Serious as per reporter). The outcome of the allergic reaction was unknown. It was unknown if the reporter considered the allergic reaction to be related to Shingrix. The company considered the allergic reaction to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 22-SEP-2025 This case was reported by a patient via interactive digital media. The patient reported allergic reaction to the first shot.; Sender's Comments: A case of Hypersensitivity, an unknown date, an unknown time after receiving Shingrix, in a patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.